[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate

C41H65NO9 — CID 76795631

IUPAC[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate
SMILESCC(=O)OC(C1CC(C)C2C(O1)C(O)C1(C)C3CCC4C(C)(C)C(OC5CN(C(=O)C6(C)COC6)CCO5)CCC45CC35CCC21C)C(C)(C)O
InChIInChI=1S/C41H65NO9/c1-23-18-25(33(36(5,6)46)49-24(2)43)50-31-30(23)38(8)14-15-41-20-40(41)13-12-28(35(3,4)26(40)10-11-27(41)39(38,9)32(31)44)51-29-19-42(16-17-48-29)34(45)37(7)21-47-22-37/h23,25-33,44,46H,10-22H2,1-9H3
InChIKeyLFUCKXZVDBXWJE-UHFFFAOYSA-N
MW715.97 g/mol
LogP5.11
Rot. Bonds6

About [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate

[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate (PubChem CID 76795631) has the molecular formula C41H65NO9 and a molecular weight of 715.97 g/mol. Its IUPAC name is [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate.

Molecular Properties

Compound Name[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate
PubChem CID76795631
Molecular FormulaC41H65NO9
Molecular Weight715.97 g/mol
Exact Mass715.47
IUPAC Name[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate
SMILESCC(=O)OC(C1CC(C)C2C(O1)C(O)C1(C)C3CCC4C(C)(C)C(OC5CN(C(=O)C6(C)COC6)CCO5)CCC45CC35CCC21C)C(C)(C)O
InChIInChI=1S/C41H65NO9/c1-23-18-25(33(36(5,6)46)49-24(2)43)50-31-30(23)38(8)14-15-41-20-40(41)13-12-28(35(3,4)26(40)10-11-27(41)39(38,9)32(31)44)51-29-19-42(16-17-48-29)34(45)37(7)21-47-22-37/h23,25-33,44,46H,10-22H2,1-9H3
InChIKeyLFUCKXZVDBXWJE-UHFFFAOYSA-N
XLogP5.11
TPSA123.99 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500715.97
LogP ≤ 55.11
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate?
The IUPAC name of [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate (CID 76795631) is [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate.
What is the SMILES notation for [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate?
The canonical SMILES for [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate is CC(=O)OC(C1CC(C)C2C(O1)C(O)C1(C)C3CCC4C(C)(C)C(OC5CN(C(=O)C6(C)COC6)CCO5)CCC45CC35CCC21C)C(C)(C)O.
What is the InChIKey of [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate?
The InChIKey is LFUCKXZVDBXWJE-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H65NO9/c1-23-18-25(33(36(5,6)46)49-24(2)43)50-31-30(23)38(8)14-15-41-20-40(41)13-12-28(35(3,4)26(40)10-11-27(41)39(38,9)32(31)44)51-29-19-42(16-17-48-29)34(45)37(7)21-47-22-37/h23,25-33,44,46H,10-22H2,1-9H3.
What are the key properties of [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate?
[2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate has a molecular weight of 715.97 g/mol, XLogP of 5.11, 6 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [2-hydroxy-1-[11-hydroxy-4,6,12,17,17-pentamethyl-18-[4-(3-methyloxetane-3-carbonyl)morpholin-2-yl]oxy-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] acetate is sourced from PubChem (CID 76795631), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).